Bayer Buys Diabetes Firm
Bayer Diabetes Care, a division of Germany's Bayer AG (BAY), has acquired Metrika, a privately-held company based in Sunnyvale, Calif., that makes a diabetes-monitoring system.
Financial details weren't disclosed. Metrika markets the A1CNow+, a meter-based system that has single-use, disposable test cartridges. A1CNow+ is a pager-sized device that people with diabetes can use to monitor HbA1c, the standard measure of blood-sugar control.
HbA1c is also known as glycated hemoglobin. The A1CNow+ provides access to HbA1c results in five minutes.
Bayer's American depositary shares fell 48 cents, or 1.1%, to $45.15 in U.S. trading Thursday.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV